A Phase 2 Study of the Safety and Efficacy of Thymosin Beta 4 for Treating Corneal Wounds

NCT00598871 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped slow recruitment

Conditions

Diabetes

Interventions

DRUG: Thymosin Beta 4 (Tβ4)
OTHER: Placebo

Sponsor

ReGenTree, LLC

Collaborators

[object Object]